CVS Health plans to split its retail drugstore business from a group that includes its insurer and pharmacy benefit manager, or PBM. The proposed breakup would put several other health businesses with the insurance and PBM operations, including primary care provider Oak Street Health, home-visit provider Signify Health and CVS’s specialty drug business. CVS shares fell 10%, according to the headline accompanying the report.
The company says separate businesses could focus on their own plans, adopt technology and improve efficiency. The move also raises questions for investors and customers. One is whether the retail pharmacy can keep its close ties to the PBM, which negotiates drug prices and manages prescription benefits. CVS says commercial agreements between the two companies would preserve their synergies. The supplied report does not give a timeline, deal terms or details about how those agreements would work.
What CVS plans to separate
CVS is proposing to place its retail drugstore business in one company and combine its insurer and PBM with other health operations in another. Those businesses include Oak Street Health, Signify Health and the specialty drug business. The plan would therefore reorganize more than the pharmacy and insurance units alone.
CVS says the two companies would have a “focused strategic agenda” and more ability to innovate, adopt technology and increase efficiency. These are the company’s stated benefits, not outcomes that have already been achieved. The report does not say how the new companies would be led, how they would be financed or when a separation could take effect.
Why CVS is revisiting a breakup
This is not the first time CVS has considered a split. In October 2024, the company began a strategic review and weighed separating its retail pharmacy and insurance units. CVS executive Joyner told CNBC that the company was then in a turnaround and lacked the flexibility, cash position and business performance needed to carry out a split.
Leerink Partners analyst Michael Cherny said the pharmacy business is now more stable. He pointed to market share gains against competitors and to gross margins stabilizing with CostVantage, a pharmacy reimbursement model CVS introduced last year. CVS describes CostVantage as more transparent. Cherny said the pharmacy business has changed from earlier periods when it faced a range of challenges it could not overcome.
- For investors: The proposed structure separates the retail pharmacy from the insurer and PBM, but CVS has not provided deal terms in the supplied report.
- For pharmacy customers: The report does not describe any planned changes to stores, prescriptions or customer services.
- For business clients: CVS says commercial agreements would preserve synergies between the pharmacy and PBM, but the details are not yet stated.
- For policy watchers: The split comes amid scrutiny of PBMs and companies that own pharmacies, insurers and benefit managers.
CVS breakup plan: what is known and what remains unclear
| Topic | What the report says | What is not specified |
|---|---|---|
| Retail pharmacy | CVS plans to separate its drugstore business from the other operations. | The report gives no details on the future company’s structure or leadership. |
| Other businesses | The insurer and PBM would be grouped with Oak Street Health, Signify Health and the specialty drug business. | No financial breakdown or operating plan for the combined group is provided. |
| Business ties | CVS says commercial agreements would preserve synergies between the pharmacy and PBM. | The report does not explain the agreements’ terms or duration. |
| Company rationale | CVS cites focus, innovation, technology adoption and efficiency as potential benefits. | No targets or expected savings are provided. |
| Market response | CVS shares fell 10%, according to the headline. | The report does not give a detailed account of trading or the reasons behind the decline. |
| Timing | The proposal was reported on Wednesday. | No completion date or approval process is described. |
Key investor questions: PBM ties, regulation and execution
A central question is whether a stand-alone retail pharmacy can keep the advantages it may gain from being linked to a PBM. PBMs negotiate drug prices and manage prescription drug benefits for insurers and employers. Some investors may view the connection as valuable. CVS’s Joyner told analysts that the relationship would continue through commercial agreements, and said the companies would not need to share one operating structure. The report does not explain how those agreements would affect costs, service or bargaining power.
The policy backdrop adds another issue for investors to weigh. PBMs face bipartisan scrutiny in Washington and in state legislatures over pricing practices, market power and possible conflicts of interest when one owner operates pharmacies, insurers and PBMs. Tennessee and Arkansas have passed laws that would ban common ownership of PBMs and pharmacies. CVS and other companies have challenged those laws in court. Cherny said state scrutiny of vertical integration could also form part of the rationale for the breakup. The report does not say the proposal is a response to any single law or court case.
Trending FAQ
What is CVS planning to split off?
CVS plans to separate its retail drugstore business from a group that would include its insurer and PBM, Oak Street Health, Signify Health and the specialty drug business.
Why does CVS say a split could help?
The company says separate organizations could follow a more focused strategy and have greater ability to innovate, adopt technology and increase efficiency. These are stated goals, not confirmed results.
Will the pharmacy lose its connection to the PBM?
CVS says synergies would be preserved through commercial agreements between the two organizations. The supplied report does not provide the agreements’ details.
Why did CVS shares fall?
The headline reports that shares fell 10%. The supplied article text does not provide a detailed explanation for the drop, so it does not establish a single cause.
Has CVS tried to break up before?
Yes. In October 2024, CVS engaged advisers in a strategic review and considered separating its retail pharmacy and insurance units. Joyner told CNBC that CVS was then in a turnaround and did not have the flexibility, cash position or business performance to execute a split.
When will the split happen?
The supplied report does not give a timetable or completion date. It also does not provide financial terms or describe the steps required to complete the separation.